Predictive Neonatal Clinical Decicion Support Platform
Why invest in NeoPrediX?
- Digital Health
- Breakthrough prediction tool
- Global market potential
- Dedicated team of scientific and market experts
Investor Media Center:
NeoPrediX PRESENT AT BIOTECH SHOWCASE™ 2022
Breakthrough Prediction Software Platform of NeoPrediX shown at BIOTECH SHOWCASE
Regensburg, Germany. 22nd of December 2021 – NeoPrediX today announced that it will be presenting virtually at the Biotech Showcase™ 2022 conference with an online presentation.
Start-up company opens first US office
NeoPrediX starts marketing its prediction software platform in USA
November 15, 2021 - With the establishment of NeoPrediX USA in Fort Lauderdale (Florida) the German/Swiss NeoPredix AG starts its US business and pushes its internationalization strategy. The start-up company develops prediction software for hospitals and neonatal units based on scientific and clinical data as well as science-based algorithms.
Who is NeoPrediX
NeoPrediX AG is a Swiss company located in Basel with subsidiaries in Regensburg, Germany and Ft. Lauderdale, Florida, USA.
Please feel free to contact us at any time for further questions and requests.